Yang Qian, Huang Jinfa, Liu Yixuan, Mai Qiqing, Zhou Yuan, Zhou Lei, Zeng Lingling, Deng Kaixian
Gynecology Department, Shunde Hospital, Southern Medical University, Foshan, 528308, China.
Stem Cell Rev Rep. 2024 Aug;20(6):1555-1568. doi: 10.1007/s12015-024-10730-6. Epub 2024 May 4.
Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) have demonstrated efficacy in repairing uterine scars, although the underlying mechanisms remain unclear.
Uterine injury was surgically induced in a rat model, followed by immediate transplantation of 5 × 10 ^ 5 hUC-MSCs to each side of the uterus. Uterine morphology was evaluated at days 14 and 30 using HE and Masson staining. Immunohistochemistry assessed macrophage polarization, angiogenesis and endometrial receptivity in the endometrium. Additionally, the regulatory effects of hUC-MSCs on macrophage polarization were explored through coculture. qRT-PCR quantified the expression of anti-inflammatory (IL10 and Arg1) and pro-inflammatory (iNOS and TNF-α) factors. Western blotting evaluated CD163 expression.
Transplantation of hUC-MSCs promoted the healing of uterine injuries and tissue regeneration while inhibiting tissue fibrosis. Immunohistochemistry at days 14 and 30 post-transplantation demonstrated the polarization of macrophages toward the M2 phenotype in the uterine injury area in the presence of hUC-MSCs. Furthermore, hUC-MSC transplantation improved angiogenesis and endometrial receptivity in the uterine injury rat model, associated with increased IL10 expression. hUC-MSC-induced angiogenesis can be resisted by depleted macrophages. In vitro coculture experiments further demonstrated that hUC-MSCs promoted IL10 expression in macrophages while suppressing TNF-α and iNOS expression. Western blotting showed enhanced CD163 expression in macrophages following hUC-MSC treatment.
hUC-MSCs contribute to the healing of uterine injuries by targeting macrophages to promote angiogenesis and the expression of anti-inflammatory factors.
人脐带间充质干细胞(hUC-MSCs)已被证明在修复子宫瘢痕方面具有疗效,但其潜在机制仍不清楚。
通过手术在大鼠模型中诱导子宫损伤,随后立即将5×10^5个hUC-MSCs移植到子宫两侧。在第14天和第30天使用苏木精-伊红(HE)和Masson染色评估子宫形态。免疫组织化学评估子宫内膜中巨噬细胞极化、血管生成和子宫内膜容受性。此外,通过共培养探索hUC-MSCs对巨噬细胞极化的调节作用。实时定量聚合酶链反应(qRT-PCR)定量抗炎(IL10和Arg1)和促炎(iNOS和TNF-α)因子的表达。蛋白质免疫印迹法评估CD163的表达。
hUC-MSCs移植促进了子宫损伤的愈合和组织再生,同时抑制了组织纤维化。移植后第14天和第30天的免疫组织化学显示,在存在hUC-MSCs的情况下,子宫损伤区域的巨噬细胞向M2表型极化。此外,hUC-MSC移植改善了子宫损伤大鼠模型中的血管生成和子宫内膜容受性,这与IL10表达增加有关。耗尽巨噬细胞可抵抗hUC-MSC诱导的血管生成。体外共培养实验进一步证明,hUC-MSCs促进巨噬细胞中IL10的表达,同时抑制TNF-α和iNOS的表达。蛋白质免疫印迹法显示,hUC-MSC处理后巨噬细胞中CD163表达增强。
hUC-MSCs通过靶向巨噬细胞促进血管生成和抗炎因子表达,有助于子宫损伤的愈合。